Barritault Denis

Barritault Denis serves as CEO at OTR3. OTR3 operates in the biotechnology sector with approximately 22.0 employees. The company is headquartered in Paris, Ile-de-France.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • 4,101 executive contacts are available in Ile-de-France.
• • Our database includes 201,468 c suite-level executives.

Outlook Microsoft Office 365 Apache reCAPTCHA WordPress.org Mobile Friendly Gravity Forms Google Font API Remote AI

matrix therapy healing regenerating agents rgta chronic wounds corneal lesions cacipliq20 cacicol20 regenerative medicine ischemic stroke ards tissue regeneration rgta technology medical devices dermatological disorders neurological disorders heparan sulfate mimetics extracellular matrix clinical studies veterinary products biomaterials wound healing skin ulcers cellular micro-environment medical research iso 13485 certification product development biotech solutions cacipliq 20 clerapliq dermapliq cosmetics for athletes research & development stem cell therapy fibrosis treatment bioengineering surgical scars collagen restoration tissue repair scaffold restoration anti-fibrotic drugs pulmonary fibrosis preclinical studies human precision-cut lung slices skin tissue engineering chronic skin ulcers veterinary comfort products pharmaceutical industry post-market vigilance clinical operations matrix therapy agents advanced therapy medicinal products biopharmaceutical products regenerative agents subcontracting partnerships medical device production hospital & health care

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

CH

Chris Harano President and CEO at Advanced BioCatalytics

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Barritault Denis, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

Barritault Denis's Position in the MessageCEO Database

• •Barritault Denis is 1 of 1 verified executive contact we track at OTR3.
• •365 verified executive contacts in biotechnology are in the MessageCEO database.
• •4,045 verified executive contacts in Ile-de-France are in the database.
• •18 verified contacts work at biotechnology companies in the 22.0 employee range (same size as OTR3).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Barritault Denis directly?

Barritault Denis's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at OTR3. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Barritault Denis work for?

Barritault Denis is CEO at OTR3, a company in the biotechnology sector with 22.0 employees. The company is based in Paris, Ile-de-France.

Can I pitch or sell to Barritault Denis?

As CEO at OTR3, Barritault Denis is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Barritault Denis directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Barritault Denis in?

Barritault Denis works in the biotechnology industry as CEO at OTR3. MessageCEO provides verified contact information for executives across all major industries.

Is Barritault Denis's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Barritault Denis's profile is kept up-to-date with the latest available information.

Last updated: July 26, 2026